Virtual Meeting to be held on October 16 hosted by Piper Sandler.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SGMT:
- Sagimet Biosciences Announces Completion of Enrollment of 120 Patients for Phase 3 Clinical Trial by Its Partner Ascletis of Denifanstat Combined with Bevacizumab for Treatment of Recurrent Glioblastoma
- Sagimet Biosciences announces completion of enrollment for denifanstat trial
- ‘Load Up,’ Says Goldman Sachs About These 2 ‘Strong Buy’ Stocks
- Sagimet Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
- Sagimet Biosciences Announces Closing of Underwriters’ Option to Purchase Additional Shares of Series A Common Stock in Connection with its Upsized Initial Public Offering